======= ARPC2 ======= == Gene Information == * **Official Symbol**: ARPC2 * **Official Name**: actin related protein 2/3 complex subunit 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10109|10109]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15144|O15144]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ARPC2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ARPC2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604224|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Functions as actin-binding component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Seems to contact the mother actin filament. |P34-Arc| |muscle cell projection membrane| |actin polymerization-dependent cell motility| |Arp2/3 protein complex| |positive regulation of lamellipodium assembly| |Arp2/3 complex-mediated actin nucleation| |positive regulation of lamellipodium organization| |regulation of lamellipodium assembly| |actin filament polymerization| |actin nucleation| |positive regulation of substrate adhesion-dependent cell spreading| |regulation of lamellipodium organization| |actin polymerization or depolymerization| |regulation of substrate adhesion-dependent cell spreading| |site of double-strand break| |protein polymerization| |ephrin receptor signaling pathway| |positive regulation of actin filament polymerization| |positive regulation of plasma membrane bounded cell projection assembly| |structural constituent of cytoskeleton| |positive regulation of cell-substrate adhesion| |positive regulation of protein polymerization| |immune response-regulating cell surface receptor signaling pathway involved in phagocytosis| |Fc-gamma receptor signaling pathway involved in phagocytosis| |Fc receptor mediated stimulatory signaling pathway| |Fc-gamma receptor signaling pathway| |positive regulation of cell morphogenesis involved in differentiation| |regulation of actin filament polymerization| |lamellipodium| |regulation of actin polymerization or depolymerization| |regulation of actin filament length| |positive regulation of supramolecular fiber organization| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |actin filament binding| |regulation of cell-substrate adhesion| |actin cytoskeleton| |positive regulation of cytoskeleton organization| |regulation of protein polymerization| |actin filament organization| |Fc receptor signaling pathway| |positive regulation of protein complex assembly| |regulation of actin filament organization| |endosome| |regulation of cell morphogenesis involved in differentiation| |neuron projection| |phagocytosis| |regulation of actin cytoskeleton organization| |glutamatergic synapse| |regulation of supramolecular fiber organization| |regulation of cellular component size| |positive regulation of cell projection organization| |regulation of actin filament-based process| |positive regulation of cell adhesion| |focal adhesion| |immune response-activating cell surface receptor signaling pathway| |regulation of protein complex assembly| |supramolecular fiber organization| |immune response-regulating cell surface receptor signaling pathway| |regulation of cell morphogenesis| |actin cytoskeleton organization| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of anatomical structure size| |positive regulation of cellular component biogenesis| |regulation of cytoskeleton organization| |positive regulation of cell development| |immune response-activating signal transduction| |actin filament-based process| |immune response-regulating signaling pathway| |positive regulation of organelle organization| |activation of immune response| |regulation of cell adhesion| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |enzyme linked receptor protein signaling pathway| |cellular protein-containing complex assembly| |membrane organization| |positive regulation of immune response| |regulation of cell development| |regulation of cellular component biogenesis| |positive regulation of cell differentiation| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |immune effector process| |cytoskeleton organization| |positive regulation of immune system process| |regulation of immune response| |positive regulation of cellular component organization| |regulation of organelle organization| |locomotion| |positive regulation of developmental process| |movement of cell or subcellular component| |protein-containing complex assembly| |regulation of immune system process| |regulation of cell differentiation| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-2.57| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.23| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.98| |[[:results:exp483|FTY720 3μM R08 exp483]]|-1.93| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-1.91| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.8| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.78| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.78| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.76| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.74| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.74| ^Gene^Correlation^ |[[:human genes:a:arpc4|ARPC4]]|0.743| |[[:human genes:a:actr3|ACTR3]]|0.673| |[[:human genes:c:commd5|COMMD5]]|0.672| |[[:human genes:a:actr2|ACTR2]]|0.602| |[[:human genes:c:commd7|COMMD7]]|0.595| |[[:human genes:c:commd3|COMMD3]]|0.565| |[[:human genes:c:ccdc22|CCDC22]]|0.562| |[[:human genes:c:commd2|COMMD2]]|0.518| |[[:human genes:v:vps29|VPS29]]|0.511| |[[:human genes:k:kiaa0196|KIAA0196]]|0.503| |[[:human genes:c:commd10|COMMD10]]|0.492| |[[:human genes:c:chka|CHKA]]|0.482| |[[:human genes:c:commd9|COMMD9]]|0.474| |[[:human genes:f:flvcr1|FLVCR1]]|0.466| |[[:human genes:c:commd4|COMMD4]]|0.454| |[[:human genes:c:commd8|COMMD8]]|0.439| |[[:human genes:c:ccdc53|CCDC53]]|0.439| |[[:human genes:c:c16orf62|C16orf62]]|0.435| |[[:human genes:k:kiaa1033|KIAA1033]]|0.433| |[[:human genes:v:vps35|VPS35]]|0.428| |[[:human genes:r:rab7a|RAB7A]]|0.423| |[[:human genes:m:mmd|MMD]]|0.41| |[[:human genes:l:lzic|LZIC]]|0.406| |[[:human genes:a:arpc3|ARPC3]]|0.404| Global Fraction of Cell Lines Where Essential: 5/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4369 * **Expression level (log2 read counts)**: 7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}